Efferocytosis and Atherosclerosis: Regulation of Phagocyte Function by MicroRNAs

Amir Tajbakhsh1, Vanessa Bianconi2, Matteo Pirro2

  • 1Halal Research Center of IRI, FDA, Tehran, Iran; Department of Modern Sciences and Technologies, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

MicroRNAs regulate efferocytosis, the process of clearing apoptotic cells, which is crucial for vascular health and preventing atherosclerosis. Understanding these microRNAs offers potential new therapies for atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Immunology

Background:

  • Efferocytosis, the clearance of apoptotic cells by phagocytes, is vital for maintaining vascular cell homeostasis and preventing atherosclerosis.
  • MicroRNAs (miRs) are implicated in regulating key processes in atherogenesis, including phagocyte accumulation and function.
  • Dysfunctional efferocytosis contributes to the development and progression of atherosclerotic plaques.

Purpose of the Study:

  • To review the role of microRNAs in regulating efferocytosis within the context of atherosclerosis.
  • To elucidate the mechanisms by which miRs influence phagocyte function and efferocytosis of apoptotic foam cells.
  • To explore the potential of miRs as therapeutic targets for anti-atherosclerotic strategies.

Main Methods:

  • Literature review of studies investigating microRNAs, efferocytosis, and atherosclerosis.
  • Analysis of cellular and molecular mechanisms linking miRs to phagocyte behavior in the arterial wall.
  • Synthesis of current knowledge on miR-mediated regulation of efferocytosis in atherosclerotic plaque.

Main Results:

  • Specific miRs modulate the recruitment and differentiation of phagocytes, including macrophages and nonprofessional phagocytes.
  • miRs influence the efferocytosis of apoptotic foam cells, a critical step in resolving inflammation within plaques.
  • miR-regulated efferocytosis impacts the inflammatory response within the atherosclerotic environment.

Conclusions:

  • MicroRNAs play a significant role in controlling efferocytosis, a key process in vascular homeostasis and atherosclerosis.
  • Targeting miRs involved in efferocytosis presents a promising avenue for developing novel anti-atherosclerotic therapies.
  • Further understanding of miR-phagocyte interactions could lead to innovative therapeutic strategies for cardiovascular disease.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
2.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
337
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
25.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
970